Glaxosmithkline Pharmaceuticals consolidated net profit rises 15.69% in the June 2026 quarter
(03 Aug 2026)

Back
Net profit of Glaxosmithkline Pharmaceuticals rose 15.69% to Rs 237.18 crore in the quarter ended June 2026 as against Rs 205.01 crore during the previous quarter ended June 2025. Sales rose 16.55% to Rs 938.44 crore in the quarter ended June 2026 as against Rs 805.17 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales938.44805.17 17
OPM %31.4931.20 -
PBDT338.29294.50 15
PBT322.45278.98 16
NP237.18205.01 16

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew